zphc semaglutide FBI issues safety warning about counterfeit versions of weight loss drug Prescribing | Ozempic® (semaglutide) injection

These events were generally mild to moderate and most resolved during treatment

Ozempic is approved to treat Type 2 diabetes, while Wegovy is a higher-dose version approved for weight loss

The release of those numbers comes just days after a watershed federal policy change: beginning July 1, 2026, eligible Medicare Part D beneficiaries can access GLP-1 medications approved for weight loss including Wegovy, oral Wegovy, Zepbound, and Foundayo for a flat $50 monthly copay through a new program called the Medicare GLP-1 Bridge

Use this coupon at checkout to enjoy a substantial discount

Thats because of previous medications that have caused those side effects